Immunosuppression as an alternative pathway in respirable particle-induced lung diseases

Puntos clave

• Immunosuppression may play a significant role in the development of lung diseases caused by respiratory particles.
• Respiratory particles can trigger inflammatory responses, potentially leading to chronic lung conditions.
• Analysis indicates that targeting the immunosuppressive pathway may offer new therapeutic options for affected individuals.
• Further investigation is needed to fully understand the relationship between particle exposure and immune response.